P
roteins have demonstrated great value as research tools and as human therapeutics. Due to the inability of virtually all proteins to spontaneously enter cells, however, exogenous proteins are predominantly restricted to interaction with extracellular targets and targets accessible through the endocytic pathway. Over the past decade, a variety of reagents for the delivery of proteins into mammalian cells have been developed including lipid-linked compounds (1), nanoparticles (2) , and fusions to receptor ligands (3, 4) . Perhaps the most commonly used method for protein delivery is genetic fusion to protein transduction domains (PTDs) including the HIV-1 transactivator of transcription (Tat) peptide, oligoarginine, and the Drosophila Antennapedia-derived penetratin peptide (5, 6) . Despite these advances, intracellular targets remain difficult to perturb using exogenous proteins; even modest success can require high concentrations of exogenous protein because of the limited potency of most current methods. Challenges for protein delivery are significantly increased in vivo, where cells in the context intact tissues and organs have proven especially difficult targets for functional protein delivery (7, 8) . The development of more potent protein transduction platforms would therefore significantly increase the scope of potential applications for protein reagents and therapeutics.
We recently described "supercharged" GFP variants that have been extensively mutated at their surface-exposed residues, resulting in extremely high theoretical net charge magnitudes ranging from Ϫ30 to ϩ48 (9) . We discovered that superpositively charged GFP variants can enter a variety of mammalian cells by binding to anionic cellsurface proteoglycans and undergoing endocytosis in an energy-dependent and clathrin-independent fashion (10) . Further, we observed that superpositive GFPs are able to form stable noncovalent complexes with nucleic acids and that ϩ36 GFP can deliver siRNA and plasmid DNA into a variety of mammalian cell lines without apparent cytotoxicity.
We hypothesized that ϩ36 GFP may also serve as a potent and general platform for the delivery of proteins into mammalian cells. We began by generating a variety of fusion proteins with ϩ36 GFP and observed that these fusions maintain the ability to rapidly (within 15 min) and potently (at low nanomolar concentrations) penetrate mammalian cells without toxicity (Supplementary Figures 1Ϫ3) .
Next we directly compared the ability of ϩ36 GFP, Tat, Arg 10 , and penetratin to deliver fused mCherry (11), a red fluorescent *Corresponding author, drliu@fas.harvard.edu.
ABSTRACT The inability of proteins to potently penetrate mammalian cells limits their usefulness as tools and therapeutics. When fused to superpositively charged GFP, proteins rapidly (within minutes) entered five different types of mammalian cells with potency up to ϳ100-fold greater than that of corresponding fusions with known protein transduction domains (PTDs) including Tat, oligoarginine, and penetratin. Ubiquitin-fused supercharged GFP when incubated with human cells was partially deubiquitinated, suggesting that proteins delivered with supercharged GFP can access the cytosol. Likewise, supercharged GFP delivered functional, nonendosomal recombinase enzyme with greater efficiencies than PTDs in vitro and also delivered functional recombinase enzyme to the retinae of mice when injected in vivo. After incubation, cells were washed under conditions confirmed to remove surfacebound protein (Supplementary Figure 5) , trypsinized, and assayed for internalized mCherry by flow cytometry (Figure 1,  panel a) . For all five cell lines and at all concentrations tested (10 nM to 2 M), ϩ36 GFP delivered ϳ10-to 100-fold more mCherry than Tat or Arg 10 . At concentrations of Յ100 nM, ϩ36 GFP also delivered ϳ6-to 20-fold more mCherry than penetratin, which approached the potency of ϩ36 GFP only in HeLa cells and only at the highest tested concentrations (1 and 2 M). These results suggest that ϩ36 GFP is a significantly more potent protein transduction agent than the widely used Tat, Arg 10 , and penetratin, especially at submicromolar concentrations. We also observed that the presence of serum in culture media modestly decreased (ϳ2-fold reduction in media containing 50% serum compared with media lacking serum) but did not abrogate the delivery of ϩ36 GFP-mCherry into cells (Supplementary Figure 5) . Delivery of mCherry into cells by ϩ36 GFP was confirmed by live-cell confocal fluorescence microscopy ( Figure 1, panel b) and by comparison with control experiments in which endocytosis is blocked at 4°C and protein remains surface-bound ( Supplementary Figure 6) .
To study the ability of proteins delivered with ϩ36 GFP to access the cytosol, we generated a ubiquitin-ϩ36 GFP fusion in which the C-terminus of ubiquitin was directly followed by ϩ36 GFP. A direct fusion of this type is recognized and processed by cytosolic deubiquitinases (DUBs), and DUBdependent deubiquitination has previously been used as an indicator of cytosolic exposure (12, 13) . A mutant form of ubiquitin (G76V) that is not a substrate for DUBs (12) was similarly fused to ϩ36 GFP to distinguish the effect of cytosolic DUBs from nonspecific proteolysis.
After a 1 h of incubation of HeLa, 3T3, or BSR cells with either 100 nM ubiquitin-ϩ36 GFP or 100 nM ubiquitin G76V ϩ36 GFP, a significant fraction (HeLa, 25 Ϯ 5.8%; 3T3, 27 Ϯ 2.4%; BSR: 24 Ϯ 4.0%) of internalized ϩ36 GFP was deubiquitinated, producing a protein equal in size to ϩ36 GFP ( Figure 2 , panel a). In contrast, in all cases the G76V mutant-ϩ36 GFP fusion was not appreciably cleaved, indicating that this reduction in size does not arise from nonspecific endosomal proteases but instead from the action of DUBs. Ubiquitin-ϩ36 GFP spiked into the cell lysis buffer prior to harvesting untreated cells was not cleaved (Figure 2 , panel a), indicating that the observed deubiquitination is a result of exposure to cytosolic DUBs and not due to contact with DUBs during the cell-harvesting procedure. Additionally, ubiquitin-ϩ36 GFP was completely deubiquitinated when incubated in HeLa cytosolic extract for 1 h, while the DUB inhibitors N-ethylmaleimide (14) and ubiquitin-aldehyde (15) blocked deubiquitination ( Figure 2 , panel b), further suggesting that the cleavage of ubiquitin-ϩ36 GFP is a result of DUB activity. Collectively, these results demonstrate that some of the ubiquitin-ϩ36 GFP protein fusion can access cytosolic enzymes in three distinct mammalian cell lines.
Next we compared the ability of ϩ36 GFP, Tat, Arg 10 , and penetratin to deliver a functional enzyme, Cre recombinase, into a variety of mammalian cells. Exogenously delivered Cre must escape the endosome, localize to the nucleus, and tetramerize to mediate DNA recombination (16) . We generated ϩ36 GFP-Cre, Tat-Cre, Arg 10 -Cre, and penetratin-Cre fusion proteins (Supplementary Figure 7 ) and tested their ability to effect recombination in HeLa cells transiently transfected with pCALNL-DsRed2 (17), a DsRed2-based Cre activity reporter plasmid. After incubation with 100Ϫ1000 nM of each Cre fusion protein for 4 h in serum-free media, cells were washed to remove surface bound protein and incubated in full media for 48 h. Delivery of Cre was assayed by following DsRed2 expression using flow cytometry and fluorescence microscopy ( Figure 3, panel a) . We observed that ϩ36 GFP-Cre generated ϳ2-to 5-fold more recombinants than the corresponding fusions with Tat, Arg 10 , or penetratin.
Cre delivery was further evaluated in a NIH-3T3 cell line harboring an integrated lacZ-based Cre-reporter (5). After incubation, treatment, and washing as described above, these cells were stained with X-Gal to identify recombinants. Consistent with the HeLa cell results, ϩ36 GFP-Cre resulted in more efficient generation of recombinants than Tat, Arg 10 , or penetratin. The efficacy of ϩ36 GFP-Cre was 10-to 100-fold higher than that of the other Cre fusions at 100 nM, 10-fold higher at 500 nM, and 5-fold higher at 1 M (Figure 3, panel b) . These findings together indicate that ϩ36 GFP can deliver substantially more functional Cre than Tat, Arg 10 , or penetratin in these cell lines.
Next, we used BSR cells to generate a Cre reporter cell line conditionally expressing the tdTomato fluorescent protein after Cre-mediated DNA recombination. Following treatment as described above, Cremediated recombination was quantified by flow cytometry. In this cell line, ϩ36 GFP was 2-to 15-fold more effective than Arg 10 or penetratin. At low concentrations, ϩ36 GFP delivered modestly higher levels of functional Cre than Tat, while higher concentrations of Tat-Cre generated ϳ2-fold more recombinants than ϩ36 GFP-Cre. This cell line exhibits unusual features, including a high metabolic rate (doubling time ϭ ϳ12 h (18)), which led us to speculate that endosomal trafficking to lysosomes may be unusually efficient in these BSR cells compared with HeLa-and 3T3-based reporter cells. Indeed, when BSR cells were incubated with the Cre fusions in the presence panel c). These results suggest that the unique cell-penetration potency of ϩ36 GFP can be more fully exploited by extending the time available for internalized protein to escape endosomes, resulting in even higher levels of delivered functional protein. In support of this hypothesis, in vitro assays reveal that while ϩ36 GFP-Cre is not active as the intact fusion (Supplementary Figure 7) , at pH 5.5Ϫ6.5 cathepsin B, a ubiquitous mammalian endosomal protease, will cleave ϩ36 GFP-Cre to generate ϩ36 GFP and active Cre ( Supplementary Figures 7 and 8) . At pH 5.0, the exopeptidase activity of cathepsin B is maximized (20), and we observed complete degradation of Cre and the loss of recombinase activity in vitro (Supplementary Figure 8) . These findings are consistent with a model in which choloroquine's ability to prevent complete acidification of lysosomes (21) extends the endosomal lifetime of active Cre and thereby enables a larger amount of the internalized enzyme to escape endosomes. Finally, we tested ϩ36 GFP as a protein delivery agent in vivo. First we examined the tissue penetration of ϩ36 GFP in the adult mouse retina. We injected 0.5 L of 100 M ϩ36 GFP into the subretinal space of CD1 adult mice. After 6 h, the retinae were harvested and analyzed by fluorescence microscopy ( Figure 2, panel d) . Most of ϩ36 GFP signal was observed near the photoreceptor outer segments, but significant signal was observed throughout the retina, including all three nuclear layers (the outer, inner, and ganglion cell layers) as well as in the cell processes. To test the ability of ϩ36 GFP to deliver functional protein in vivo, we injected ϩ36 GFP-Cre into the subretinal space of RC::PFwe mouse p0 pups containing a LoxP-flanked transcriptional terminator upstream of a nuclear lacZ reporter gene (22) . Three days after injection of 0.5 L of 40 M wild-type Cre, Tat-Cre, or ϩ36 GFPCre, retinae were harvested, fixed, and stained with X-gal (Figure 2, panel e) . Injection of ϩ36 GFP-Cre generated an average of 715 recombined cells per injected retina (n ϭ 6), Tat-Cre generated an average of 318 recombined cells (n ϭ 6), and wild-type Cre generated an average of 117 recombined cells per retina (n ϭ 4). To our knowledge, this is the first report of functional delivery of an enzyme into retinal cells in vivo.
We also performed additional complete sets of mCherry and Cre delivery experiments in vitro using ϩ36 GFP, Tat, and oligoarginine fusion proteins constructed with linkers and fusion orientations distinct from the examples presented above. For both sets of additional experiments we observed results that are qualitatively similar to those in Figures 1Ϫ3 (Supplementary Figures 9  and 10 ). The delivery of mCherry by ϩ36 GFP in these alternative fusion proteins was ϳ10-to 100-fold more potent than mCherry delivery by either Tat or oligoarginine, and the delivery of functional Cre recombinase by ϩ36 GFP in these alternative fusion proteins was ϳ3-to 5-fold more potent than Cre delivery by Tat or oligoarginine. These results collectively indicate that the findings described in this work are not unique to a specific protein construct but instead are more generally applicable.
In conclusion, side-by-side comparisons of ϩ36 GFP, Tat, Arg 10 and penetratin fused to mCherry or Cre recombinase revealed that fusions with supercharged GFP result in dramatically higher levels of internalized protein (up to ϳ100-fold) and in significantly greater efficiencies of Cre-induced recombination (up to ϳ10-fold) than three currently used protein transduction domains in a variety of mammalian cell lines. Functional Cre recombinase can also be delivered to cells upon injection in vivo using ϩ36 GFP. These results collectively demonstrate the potential of supercharged proteins as an unusually potent in vitro and in vivo protein delivery platform.
METHODS
For complete experimental methods including details of cell lines, cell culture, protein purification, deubiquitination assay, and all sequences of all proteins, see Supporting Information.
Live-Cell Imaging. Cells were plated onto 35-mm glass-bottom microwell dishes with a No. 1.5 cover glass (MatTek) at a density of 10 6 cells per plate. After 18 h, cells were washed once with cold PBS and incubated with protein in serum-free DMEM. After incubation, cells were washed three times with cold 20 U mL Ϫ1 heparin in PBS to remove membrane-bound protein, imaged in prewarmed HEPES imaging solution (1 mM MgCl 2 , 5 mM KCl, 5 mM CaCl 2 , 150 mM NaCl, 1.9 g L Ϫ1 glucose, 1.9 g L Ϫ1 albumin, 20 mM HEPES, pH 7.4, 37°C). Cells were imaged on an Olympus IX71 spinning disk confocal microscope on a heated stage with a 100X objective lens. GFP and mCherry were visualized with a 491 and 561 nm excitation laser, respectively. Images were prepared using OpenLab software.
For live-cell images of Cre reporter cells, cells were treated with 500 nM ϩ36 GFP-Cre as described below for analysis of Cre recombination and imaged on an Olympus IX51 fluorescent microscope with a DP30BW black and white camera. Images are false-color overlays of the fluorescent signal on a bright-field image. LacZ-positive cells were imaged on an IX70 microscope under brightfield illumination with a DP70 camera.
Flow Cytometry and mCherry Delivery Assays. Cells were plated onto a 48-well plate at a density of 5 ϫ 10 5 cells per well. After 18 h, cells were washed once with cold PBS and incubated with protein in serum-free DMEM. After incubation, cells were washed three times with cold 20 U mL Ϫ1 heparin in PBS to remove membrane-bound protein, trypsinized, resuspended in 500 L of full media and placed on ice. Cells were analyzed on either a LSRII or Fortessa flow cytometer (BD Biosciences) for GFP internalization (ex, 488 nm) or mCherry internalization (ex, 561 nm). Cells were gated for live cells and at least 5 ϫ 10 3 live cells were analyzed for each treatment. Data was analyzed with FlowJo software (Tree Star, Inc.)
In Vitro Cre Delivery Assays. HeLa cells were plated at 3 ϫ 10 4 cells per well in 48-well plates. After 16 h, cells were transfected with pCALNLDsRed2 (17) using Effectene transfection reagent (Qiagen). After incubation with 100Ϫ1000 nM of each Cre fusion protein for 4 h in serum-free DMEM, cells were washed three times with 20 U mL Ϫ1 heparin in PBS and incubated in full media for 48 h. Delivery of Cre was assayed by following DsRed2 expression using flow cytometry and fluorescence microscopy.
Cre reporter 3T3 cells were plated at 1 ϫ 10 5 cells per well in 48-well plates. After 16 h, cells were incubated with various concentrations of protein for 4 h in serum-free media. Cells were washed with three times with 20 U mL Ϫ1 heparin in PBS and incubated in full media for 48 h. Recombined cells were quantified by X-gal staining and manual counting.
BSR cells were obtained from Matthias Schnell (Thomas Jefferson University). A pQCXIX MMLV retrovirus (Clontech) containing the tdTomato cre reporter construct was generated by subcloning the tdTomato gene (Clontech) into a pCALNL backbone (17) and packaged using Plat-E cells (23) . BSR cells were infected with retrovirus and integrants were selected for 1 week in the presence of 1 mg mL Ϫ1 G418 (Sigma). BSR.LNL.tdTomato cells were plated at 1 ϫ 10 5 cells per well in 48-well plates. After 16 h, cells were incubated with various concentrations of protein for 4 h in serum-free media. Cells were washed with three times with 20 U mL Ϫ1 heparin in PBS and incubated in full media for 48 h.
For chloroquine treatment of BSR cells, cells were incubated with Cre fusion proteins for 4 h in serum-free media containing 100 M chloroquine, washed three times with 20 U mL Ϫ1 heparin in PBS, and incubated 12 h in full media containing 100 M chloroquine. Following this incubation, cells were washed once with PBS and incubated a further 36 h in full media without chloroquine. Delivery of Cre was assayed by following tdTomato expression using flow cytometry and fluorescence microscopy.
For fluorescent Cre reporters, recombinants were identified by flow cytometry as those cells of the live-cell population that exhibited fluorescence significantly higher than that of nontreated reporter cells. Typically, the recombined population exhibited fluorescence at least 10-fold higher than the nonrecombined cells and were readily detected as a distinct subpopulation. Fluorescence gates were drawn accordingly to quantitate recombined and nonrecombined cells.
In Vivo Cre Delivery. RC::PFwe mice were obtained from Susan Dymecki (Harvard University). All of the experiments in this study were approved by the Institutional Animal Care and Use Committee at Harvard University. Adult CD1 mice were subretinally injected with 0.5 L of 100 M ϩ36 GFP. After 6 h, the retinae were harvested and analyzed by fluorescence microscopy. RC:PFwe p0 pups were subretinally injected with 0.5 L of 40 M wtCre, Tat-Cre, or ϩ36 GFP-Cre. After 72 h, retinae were harvested and fixed with 0.5% glutaraldehyde. Fixed retinae were stained with X-gal overnight and embedded in 50% OCT, 50% of 30% sucrose and stored at Ϫ80°C. Retinae were cut into 30 m sections and imaged for X-gal staining on a Zeiss Axiophot brightfield microscope with a Nikon CXM-1200F camera. Delivery of Cre was assayed by manually counting LacZ ϩ cells.
